奥马佐单抗
医学
加药
免疫球蛋白E
哮喘
药效学
恶化
临床试验
过敏性哮喘
药理学
内科学
免疫学
抗体
药代动力学
作者
Günther Hochhaus,L Brookman,Howard Fox,Charles L. Johnson,John G. Matthews,Song Ren,Yamo Deniz
标识
DOI:10.1185/030079903125002171
摘要
The clinical efficacy of omalizumab has been optimised through the development of an individualised dosing table that emerged from an understanding of the pharmacodynamics of this agent.
科研通智能强力驱动
Strongly Powered by AbleSci AI